Another study with a mouse cancer model simulating the anatomical and functional features found in human oral cancer patients demonstrated that anti-NGF treatment decreased plasma TNF-α and IL-6 levels [70]. The gene discussed is NGF; the disease is lip and oral cavity carcinoma.